These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 28011764)
1. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin. Kegelman TP; Wu B; Das SK; Talukdar S; Beckta JM; Hu B; Emdad L; Valerie K; Sarkar D; Furnari FB; Cavenee WK; Wei J; Purves A; De SK; Pellecchia M; Fisher PB Proc Natl Acad Sci U S A; 2017 Jan; 114(2):370-375. PubMed ID: 28011764 [TBL] [Abstract][Full Text] [Related]
2. MDA-9/syntenin is a key regulator of glioma pathogenesis. Kegelman TP; Das SK; Hu B; Bacolod MD; Fuller CE; Menezes ME; Emdad L; Dasgupta S; Baldwin AS; Bruce JN; Dent P; Pellecchia M; Sarkar D; Fisher PB Neuro Oncol; 2014 Jan; 16(1):50-61. PubMed ID: 24305713 [TBL] [Abstract][Full Text] [Related]
3. The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion. Das SK; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Sarkar D; Emdad L; Fisher PB Cancer Res; 2018 Jun; 78(11):2852-2863. PubMed ID: 29572229 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β. Pradhan AK; Maji S; Bhoopathi P; Talukdar S; Mannangatti P; Guo C; Wang XY; Cartagena LC; Idowu M; Landry JW; Sarkar D; Emdad L; Cavenee WK; Das SK; Fisher PB Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34016751 [TBL] [Abstract][Full Text] [Related]
5. MDA-9/syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cells. Aissaoui H; Prévost C; Boucharaba A; Sanhadji K; Bordet JC; Négrier C; Boukerche H J Biol Chem; 2015 Feb; 290(6):3333-48. PubMed ID: 25505176 [TBL] [Abstract][Full Text] [Related]
6. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression. Gangemi R; Mirisola V; Barisione G; Fabbi M; Brizzolara A; Lanza F; Mosci C; Salvi S; Gualco M; Truini M; Angelini G; Boccardo S; Cilli M; Airoldi I; Queirolo P; Jager MJ; Daga A; Pfeffer U; Ferrini S PLoS One; 2012; 7(1):e29989. PubMed ID: 22267972 [TBL] [Abstract][Full Text] [Related]
7. Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis. Pradhan AK; Modi J; Maji S; Kumar A; Bhoopathi P; Mannangatti P; Guo C; Afosah DK; Mochel MC; Mukhopadhyay ND; Kirkwood JM; Wang XY; Desai UR; Sarkar D; Emdad L; Das SK; Fisher PB Mol Cancer Ther; 2023 Oct; 22(10):1115-1127. PubMed ID: 37721536 [TBL] [Abstract][Full Text] [Related]
8. Regulation of protective autophagy in anoikis-resistant glioma stem cells by SDCBP/MDA-9/Syntenin. Talukdar S; Pradhan AK; Bhoopathi P; Shen XN; August LA; Windle JJ; Sarkar D; Furnari FB; Cavenee WK; Das SK; Emdad L; Fisher PB Autophagy; 2018; 14(10):1845-1846. PubMed ID: 30118375 [TBL] [Abstract][Full Text] [Related]
9. Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor. Das SK; Kegelman TP; Pradhan AK; Shen XN; Bhoopathi P; Talukdar S; Maji S; Sarkar D; Emdad L; Fisher PB Mol Cancer Ther; 2019 Nov; 18(11):1997-2007. PubMed ID: 31345950 [TBL] [Abstract][Full Text] [Related]
10. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells. Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461 [TBL] [Abstract][Full Text] [Related]
11. RETRACTED: mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB. Boukerche H; Su ZZ; Emdad L; Sarkar D; Fisher PB Cancer Res; 2007 Feb; 67(4):1812-22. PubMed ID: 17308124 [TBL] [Abstract][Full Text] [Related]
12. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis. Das SK; Guo C; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Emdad L; Subler MA; Windle JJ; Sarkar D; Wang XY; Fisher PB Oncotarget; 2016 Jul; 7(30):46848-46861. PubMed ID: 27341128 [TBL] [Abstract][Full Text] [Related]
13. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin. Hwangbo C; Kim J; Lee JJ; Lee JH Cancer Res; 2010 Feb; 70(4):1645-55. PubMed ID: 20145126 [TBL] [Abstract][Full Text] [Related]
14. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB. Boukerche H; Aissaoui H; Prévost C; Hirbec H; Das SK; Su ZZ; Sarkar D; Fisher PB Oncogene; 2010 May; 29(21):3054-66. PubMed ID: 20228839 [TBL] [Abstract][Full Text] [Related]
15. Targeting tumor invasion: the roles of MDA-9/Syntenin. Kegelman TP; Das SK; Emdad L; Hu B; Menezes ME; Bhoopathi P; Wang XY; Pellecchia M; Sarkar D; Fisher PB Expert Opin Ther Targets; 2015 Jan; 19(1):97-112. PubMed ID: 25219541 [TBL] [Abstract][Full Text] [Related]
19. MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma. Wang LK; Pan SH; Chang YL; Hung PF; Kao SH; Wang WL; Lin CW; Yang SC; Liang CH; Wu CT; Hsiao TH; Hong TM; Yang PC Oncotarget; 2016 Jan; 7(1):386-401. PubMed ID: 26561205 [TBL] [Abstract][Full Text] [Related]
20. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src. Boukerche H; Su ZZ; Prévot C; Sarkar D; Fisher PB Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15914-9. PubMed ID: 18832467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]